Biblio Discovery — Demo Discovery Service

2 results for "Colm Farrell"

Showing 1–2 · 0.21 seconds · RSS

  1. Journal Article

    Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus

    Kefeng Sun; Siobhan Hayes; Colm Farrell et al.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 12 No. 5 · 2023 · English · DOAJ Scopus

    Abstract Maribavir was approved by the US Food and Drug Administration for the treatment of patients aged ≥12 years and weighing ≥35 kg with posttransplant cytomegalovirus infection/disease refractory (with/without resistance) to valganciclovir, ganciclovir, cidofovir, or foscarnet, with an oral…

  2. Journal Article

    Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials

    Maria Pitsiu; Özkan Yalkinoglu; Colm Farrell et al.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 12 No. 8 · 2023 · English · DOAJ Scopus

    Abstract B cell stimulating factor (BLyS) and a proliferation‐inducing ligand (APRIL) are targets for novel treatments in patients with systemic lupus erythematosus (SLE). Atacicept is a recombinant, soluble fusion protein that blocks BLyS and APRIL activity. This study characterized the…